Paid Clinical Trials in Lone Tree, CO
As of September 2026, 84 paid clinical trials are recruiting in Lone Tree, Colorado. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Lone Tree offers studies at sites including UCHealth Lone Tree Health Center for conditions such as Anatomic Stage II Breast Cancer AJCC v8, Breast Cancer, Carcinoma, Non-Small-Cell Lung, Lung Non-Small Cell Carcinoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Lone Tree
Trials by drug in Lone Tree
Filter results
Newly added in Lone Tree
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
82 clinical trials
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients
Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
A Study of YL201 in Patients With Advanced Solid Tumors
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer
Top Research Study Locations in Lone Tree
Researchers run research studies in Lone Tree, CO at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| UCHealth Lone Tree Health Center | Anatomic Stage II Breast Cancer AJCC v8, Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8 | 16 |
| Kaiser Permanente-Lone Tree | Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 13 |
| Rocky Mountain Cancer Centers, LLP | Colorectal Neoplasms, Advanced/Metastatic Urothelial Cancer, Breast Cancer | 10 |
| Rocky Mountain Cancer Centers | Advanced/Metastatic Solid Tumors, Carcinoma, Non-Small Cell Lung, Carcinoma, Non-Small-Cell Lung | 8 |
| Rocky Mountain Cancer Centers-Sky Ridge | Acral Lentiginous Melanoma, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 5 |
| Colorado Center for Reproductive Medicine | Infertility, AMH, Healthy | 2 |
| Denver Research and Technology Lab | Hearing Impairment, Hearing Loss | 2 |
| Lone Tree Medical Center | Carcinoma, Non-Small-Cell Lung, Inferior Vena Cava Thrombosis, Kidney Cancer | 2 |
| Rocky Mountain Cancer Centers LLP | Breast Cancer, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma | 2 |
| Rocky Mountain Cancer Centers,LLP | Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, Advanced/Metastatic Non-Small Cell Lung Cancer | 2 |
| UCHealth Lone Tree Medical Center | Breast Cancer, Breast Cancer and Pregnancy, Implementation Strategy Bundles for Structured Follow-up | 2 |
| University of Colorado Health - Lone Tree Medical Center | Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostate Cancer Metastatic, Prostatic Neoplasms | 2 |
| Rocky Mountain Cancer Centers (RMCC) | Colon Adenocarcinoma, Rectal Adenocarcinoma, Lung Neoplasm Malignant | 2 |
| 003 | Advanced Solid Tumor | 1 |
| Beauty by Buford | Capsular Contracture Associated With Breast Implant, Capsular Contracture Grade III, Capsular Contracture Grade IV | 1 |
| Centeno-Schultz Clinic | Degenerative Disc Disease | 1 |
| Clinical Study Site | Non-Small Cell Lung Cancer | 1 |
| GSK Investigational Site | Irritable Bowel Syndrome | 1 |
| Institute of Esophageal and Reflux Surgery | Large Hiatal Hernia, Paraesophageal Hernia | 1 |
| Peak Gastroenterology Surgery Center | Moderately to Severely Active Crohns Disease | 1 |
| Rocky Mountain Cancer Centers - Lone Tree | Non Small Cell Lung Carcinoma | 1 |
| Rocky Mountain Cancer Centers, LLP - Oncology | Advanced Solid Tumor, Malignant Peripheral Nerve Sheath Tumors, Mesothelioma | 1 |
| Rocky Mountain Cancer Centers, LLP- Aurora | Metastatic Colorectal Cancer | 1 |
| Rocky Mountain Cancer Centers-Lone Tree | Essential Thrombocythemia | 1 |
| Rocky Mountain Kidney Care - Lone Tree | Chronic Kidney Disease, Receiving Dialysis, Dialysis, ESRD (End-Stage Renal Disease) | 1 |
Active & Upcoming Studies in Lone Tree (2026)
Recruiting trials in Lone Tree grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (62 active studies)
- Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma · Phase 3 · Immuneering Corporation
- Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer · Phase 2, Phase 3 · Pfizer
Diabetes & metabolic (1 active study)
- PATHWEIGH: Pragmatic Weight Management in Primary Care · University of Colorado, Denver
Common conditions studied in Lone Tree
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies)
- Breast Cancer (4 active studies)
- Carcinoma, Non-Small-Cell Lung (3 active studies)
- Lung Non-Small Cell Carcinoma (3 active studies)
- Muscle Invasive Bladder Urothelial Carcinoma (3 active studies)
- Stage IIIB Lung Cancer AJCC v8 (3 active studies)
Leading research sponsors in Lone Tree
- National Cancer Institute (NCI)
- NRG Oncology
- Pfizer
- SWOG Cancer Research Network
- University of Colorado, Denver
Frequently asked questions
How many paid clinical trials are currently recruiting in Lone Tree?
There are approximately 84 recruiting clinical trials in Lone Tree, Colorado listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Lone Tree pay participants?
Most recruiting trials in Lone Tree compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Lone Tree?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Lone Tree?
The most common conditions under active study in Lone Tree include Anatomic Stage II Breast Cancer AJCC v8 (4), Breast Cancer (4), Carcinoma, Non-Small-Cell Lung (3), Lung Non-Small Cell Carcinoma (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Lone Tree?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Lone Tree on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Lone Tree?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Lone Tree?
Recruiting research sites in Lone Tree include UCHealth Lone Tree Health Center, Kaiser Permanente-Lone Tree, Rocky Mountain Cancer Centers, LLP, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Lone Tree right now?
The largest active categories in Lone Tree are Cancer & tumors (62), Diabetes & metabolic (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.